Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in SLE (The ABC Study)
NCT02270957Phase 2Completed
- Sponsor
- Oklahoma Medical Research Foundation
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in systemic lupus erythematosus (SLE), sponsored by Oklahoma Medical Research Foundation. Started Jan 2014; status: completed.
02
Drugs
abatacept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02270957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270957.